Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand

HPV Testing Clinical Trial

Official title:

The Thai Red Cross AIDS Research Centre

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02155231
• Other study ID #: Anal HPV and AIN among MSM
• Status: Recruiting
• Start date: February 2013
• Est. completion date: December 2025

Study information

• Verified date: April 2022
• Source: Thai Red Cross AIDS Research Centre
• Contact: Nittaya Phanuphak,, MD
• Phone: 881 8253544
• Email: nittaya.p[@]trcarc.org
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

OBJECTIVES

1. To determine the prevalence and incidence of anal HPV infection, including infection with high-risk HPV types, among MSM in Indonesia, Malaysia, and Thailand.

2. To study the prevalence and incidence of HGAIN among these MSM.

3. To evaluate risk factors, including HIV status, for anal high-risk HPV infection and HGAIN among these MSM.

Study population An approximately 75 HIV-positive and 75 HIV-negative MSM who attended the study clinic in Kuala Lumpur, Jakarta, and Bangkok will be enrolled. The study will also enroll 185 HIV-positive and 95 HIV-negative MSM who are previous participants of the MSM VCT study. There will be approximately 260 HIV-positive and 170 HIV-negative MSM in total in this study.

Description:

This is a prospective cohort study that will newly enroll approximately 150 MSM in Kuala Lumpur, Jakarta, and Bangkok and follow them prospectively with a group of 280 MSM who are previous participants of a study entitled "Multidisciplinary services to enhance HIV testing and linkage to care among MSM" (MSM VCT study) in Jakarta, Bali, and Bangkok. Newly enrolled MSM will have three study visits at baseline, month 6, and at month 12. MSM who are previous participants of the MSM VCT study will only have one study visit.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 430
• Est. completion date: December 2025
• Est. primary completion date: December 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

1. Male with history of anal sex with men or previous participants of the MSM VCT study.

2. Age 18 years old or older.

3. Indonesian or Malaysian or Thai citizen as identified by the Indonesian or Malaysian or Thai National Identification card.

4. Willing to provide location or contact information and allow contact.

5. Available for follow-up for the planned study duration.

6. Understand the study and sign informed consent form.

Exclusion Criteria:

1. History of prior treatment for anal cancer OR had anal cytology or high-resolution anoscopy or infrared coagulation within 12 months prior to enrollment OR had trichloroacetic acid or podophyllin application of the intraanal area in the past month OR evidence of active concurrent intraanal or perianal bacterial or herpes simplex infection.

2. Persons who have a history of a medical or psychiatric disorder by investigator's interview and physical examination according to standard practices, that in the judgment of the investigator(s), would interfere with ability to give informed consent.

Related Conditions & MeSH terms

• HPV Testing

Locations

Country	Name	City	State
Thailand	The Thai Red Cross AIDS Research Centre	Pathum Wan	Bangkok

Sponsors (2)

Lead Sponsor	Collaborator
Thai Red Cross AIDS Research Centre	Verein Aids Life through TREAT Asia

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	prevalence and incidence of anal HPV infection, including infection with high-risk HPV types, among MSM in Indonesia, Malaysia, and Thailand.		December 1,2014 (up to 2 years)